You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 18, 2024

Claims for Patent: 8,598,332


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 8,598,332
Title:Methods and means for obtaining modified phenotypes
Abstract: Methods and means are provided for reducing the phenotypic expression of a nucleic acid of interest in eucaryotic cells, particularly in plant cells, by introducing chimeric genes encoding sense and antisense RNA molecules directed towards the target nucleic acid, which are capable of forming a double stranded RNA region by base-pairing between the regions with sense and antisense nucleotide sequence or by introducing the RNA molecules themselves. Preferably, the RNA molecules comprises simultaneously both sense and antisense nucleotide sequence.
Inventor(s): Waterhouse; Peter Michael (Newton, AU), Wang; Ming-Bo (Cranberra, AU), Graham; Michael Wayne (Jindalee, AU), Smith; Neil A. (Cook, AU)
Assignee: Bayer CropScience N.V. (Diegem, BE)
Application Number:09/287,632
Patent Claims:1. A method for reducing the phenotypic expression of a nucleic acid of interest, which is normally capable of being expressed in a plant cell, comprising the step of introducing into said plant cell a chimeric DNA comprising the following operably linked parts: a) a promoter, operative in said plant cell; b) a DNA region, which when transcribed, yields an RNA molecule comprising an RNA region capable of forming an artificial hairpin RNA structure comprising two annealing RNA sequences, wherein one of the annealing RNA sequences of the hairpin RNA structure comprises a sense sequence that is identical to at least 20 consecutive nucleotides of the nucleotide sequence of said nucleic acid of interest, and wherein the second of said annealing RNA sequences comprises an antisense sequence that is identical to at least 20 consecutive nucleotides of the complement of at least part of said nucleotide sequence of said nucleic acid of interest, and wherein said DNA region comprises an intron heterologous to said sense sequence; and c) a DNA region involved in transcription termination and polyadenylation.

2. A method for reducing the phenotypic expression of a nucleic acid of interest, which is normally capable of being expressed in a plant cell, comprising the step of introducing into said plant cell a chimeric DNA comprising the following operably linked parts: a) a promoter, operative in said plant cell; b) a DNA region, which when transcribed, yields an RNA molecule with a nucleotide sequence comprising i) a sense nucleotide sequence including at least 20 consecutive nucleotides having 100% sequence identity with at least 20 consecutive nucleotides of the nucleotide sequence of said nucleic acid of interest; and ii) an antisense nucleotide sequence including at least 20 consecutive nucleotides having 100% sequence identity with the complement of said at least 20 consecutive nucleotides of said sense nucleotide sequence; wherein the RNA is capable of forming an artificial hairpin RNA structure with a double stranded RNA stem by base-pairing between the regions with sense and antisense nucleotide sequence such that said at least 20 consecutive nucleotides of the sense sequence basepair with said at least 20 consecutive nucleotides of the antisense sequence, and wherein said DNA region comprises an intron heterologous to said sense nucleotide sequence; and c) a DNA region involved in transcription termination and polyadenylation.

3. The method of claim 2, wherein said RNA molecule further comprises a spacer nucleotide sequence located between said sense and said antisense nucleotide sequence.

4. The method of claim 2, wherein said sense nucleotide sequence comprises at least about 550 consecutive nucleotides having 100% sequence identity with at least about 550 consecutive nucleotides of the nucleotide sequence of said nucleic acid of interest.

5. The method of claim 2, wherein said nucleic acid of interest is a gene integrated in the genome of said plant cell.

6. The method of claim 5, wherein said gene is an endogenous gene.

7. The method of claim 5, wherein said gene is a foreign transgene.

8. The method of claim 2, wherein said chimeric DNA is stably integrated in the genome of said plant cell.

9. The method of claim 2, wherein said nucleic acid of interest is comprised in the genome of an infecting virus.

10. The method of claim 9, wherein said infecting virus is an RNA virus.

11. The method of claim 2, wherein said plant cell is comprised within a plant.

12. A plant cell, comprising a nucleic acid of interest, which is normally capable of being phenotypically expressed, further comprising a chimeric DNA molecule comprising the following operably linked parts: a) a promoter, operative in said plant cell; b) a DNA region, which when transcribed, yields an RNA molecule with at least one RNA region with a nucleotide sequence comprising i) a sense nucleotide sequence including at least 20 consecutive nucleotides having 100% sequence identity with at least 20 consecutive nucleotides of the nucleotide sequence of the nucleic acid of interest; and ii) an antisense nucleotide sequence including at least 20 consecutive nucleotides having 100% sequence identity with the complement of said at least 20 consecutive nucleotides of said sense nucleotide sequence; wherein the RNA is capable of forming an artificial hairpin RNA structure with a double stranded RNA stem by base-pairing between the regions with sense and antisense nucleotide sequence, and wherein said DNA region comprises an intron heterologous to said sense nucleotide sequence; and c) a DNA region involved in transcription termination and polyadenylation.

13. A plant comprising the plant cell of claim 12.

14. The method of claim 2, wherein said intron is located between part of said DNA region which when transcribed yields said sense nucleotide sequence and part of said DNA region which when transcribed yields said antisense nucleotide sequence.

15. The plant cell of claim 12, wherein said intron is located between part of said DNA region which when transcribed yields said sense nucleotide sequence and part of said DNA region which when transcribed yields said antisense nucleotide sequence.

16. The method of claim 2, wherein said sense nucleotide sequence includes at least 50 consecutive nucleotides having 100% sequence identity with at least 50 consecutive nucleotides of the nucleotide sequence of said nucleic acid of interest, and said antisense nucleotide sequence includes at least 50 consecutive nucleotides having 100% sequence identity with the complement of said at least 50 consecutive nucleotides of said sense nucleotide sequence.

17. The method of claim 2, wherein said sense nucleotide sequence includes at least 100 consecutive nucleotides having 100% sequence identity with at least 100 consecutive nucleotides of the nucleotide sequence of said nucleic acid of interest, and said antisense nucleotide sequence includes at least 100 consecutive nucleotides having 100% sequence identity with the complement of said at least 100 consecutive nucleotides of said sense nucleotide sequence.

18. The method of claim 16 wherein said intron is located between the DNA region encoding said sense nucleotide sequence and the DNA region encoding said antisense nucleotide sequence.

19. The method of claim 17, wherein said intron is located between part of said DNA region which when transcribed yields said sense nucleotide sequence and part of said DNA region which when transcribed yields said antisense nucleotide sequence.

20. The plant cell of claim 12, wherein said sense nucleotide sequence includes at least 50 consecutive nucleotides having 100% sequence identity with at least 50 consecutive nucleotides of the nucleotide sequence of said nucleic acid of interest, and said antisense nucleotide sequence includes at least 50 consecutive nucleotides having 100% sequence identity with the complement of said at least 50 consecutive nucleotides of said sense nucleotide sequence.

21. The plant cell of claim 12, wherein said sense nucleotide sequence includes at least 100 consecutive nucleotides having 100% sequence identity with at least 100 consecutive nucleotides of the nucleotide sequence of said nucleic acid of interest, and said antisense nucleotide sequence includes at least 100 consecutive nucleotides having 100% sequence identity with the complement of said at least 100 consecutive nucleotides of said sense nucleotide sequence.

22. The plant cell of claim 20, wherein said intron is located between part of said DNA region which when transcribed yields said sense nucleotide sequence and part of said DNA region which when transcribed yields said antisense nucleotide sequence.

23. The plant cell of claim 21, wherein said intron is located between part of said DNA region which when transcribed yields said sense nucleotide sequence and part of said DNA region which when transcribed yields said antisense nucleotide sequence.

24. A chimeric DNA comprising the following operably linked parts: a) a promoter, operative in a plant cell; b) a DNA region, which when transcribed, yields an RNA molecule comprising an RNA region capable of forming an artificial hairpin RNA structure comprising two annealing RNA sequences, wherein one of the annealing RNA sequences of the hairpin RNA structure comprises a sense sequence identical to at least 20 consecutive nucleotides of the nucleotide sequence of a nucleic acid of interest, and wherein the second of said annealing RNA sequences comprises an antisense sequence identical to at least 20 consecutive nucleotides of the complement of at least part of said nucleotide sequence of said nucleic acid of interest, and wherein said DNA region comprises an intron heterologous to said sense sequence; and c) a DNA region involved in transcription termination and polyadenylation.

25. A chimeric DNA comprising the following operably linked parts: a) a promoter, operative in a plant cell; b) a DNA region, which when transcribed, yields an RNA molecule with a nucleotide sequence comprising i) a sense nucleotide sequence including at least 20 consecutive nucleotides having 100% sequence identity with at least 20 consecutive nucleotides of the nucleotide sequence of a nucleic acid of interest; and ii) an antisense nucleotide sequence including at least 20 consecutive nucleotides having 100% sequence identity with the complement of said at least 20 consecutive nucleotides of said sense nucleotide sequence; wherein the RNA is capable of forming an artificial hairpin RNA structure with a double stranded RNA stem by base-pairing between the regions with sense and antisense nucleotide sequence such that said at least 20 consecutive nucleotides of the sense sequence basepair with said at least 20 consecutive nucleotides of the antisense sequence, wherein said DNA region comprises an intron heterologous to said region with sense nucleotide sequence; and c) a DNA region involved in transcription termination and polyadenylation.

26. The chimeric DNA of claim 25, wherein said intron is located between part of said DNA region which when transcribed yields said sense nucleotide sequence and part of said DNA region which when transcribed yields said antisense nucleotide sequence.

27. The chimeric DNA of claim 25, wherein said sense nucleotide sequence includes at least 50 consecutive nucleotides having 100% sequence identity with at least 50 consecutive nucleotides of the nucleotide sequence of said nucleic acid of interest, and said antisense nucleotide sequence includes at least 50 consecutive nucleotides having 100% sequence identity with the complement of said at least 50 consecutive nucleotides of said sense nucleotide sequence.

28. The chimeric DNA of claim 25, wherein said sense nucleotide sequence includes at least 100 consecutive nucleotides having 100% sequence identity with at least 100 consecutive nucleotides of the nucleotide sequence of said nucleic acid of interest, and said antisense nucleotide sequence includes at least 100 consecutive nucleotides having 100% sequence identity with the complement of said at least 100 consecutive nucleotides of said sense nucleotide sequence.

29. The chimeric DNA of claim 27, wherein said intron is located between part of said DNA region which when transcribed yields said sense nucleotide sequence and part of said DNA region which when transcribed yields said antisense nucleotide sequence.

30. The chimeric DNA of claim 28, wherein said intron is located between part of said DNA region which when transcribed yields said sense nucleotide sequence and part of said DNA region which when transcribed yields said antisense nucleotide sequence.

31. A method for reducing the phenotypic expression of a nucleic acid of interest, which is normally capable of being expressed in a plant cell, comprising the step of introducing into said plant cell a chimeric DNA comprising the following operably linked parts: a) a promoter, operative in said plant cell; b) a DNA region, which when transcribed, yields an RNA molecule comprising an RNA region capable of forming an artificial hairpin RNA structure comprising two annealing RNA sequences, wherein one of the annealing RNA sequences of the hairpin RNA structure comprises a sense sequence identical to at least 20 consecutive nucleotides of the nucleotide sequence of said nucleic acid of interest, and wherein the second of said annealing RNA sequences comprises an antisense sequence identical to at least 20 consecutive nucleotides of the complement of at least part of said nucleotide sequence of said nucleic acid of interest, and wherein said DNA region comprises an intron; and c) a DNA region involved in transcription termination and polyadenylation.

32. A method for reducing the phenotypic expression of a nucleic acid of interest, which is normally capable of being expressed in a plant cell, comprising the step of introducing into said plant cell, a chimeric DNA comprising the following operably linked parts: a) a promoter, operative in said plant cell; b) a DNA region, which when transcribed, yields an RNA molecule with a nucleotide sequence comprising i) a sense nucleotide sequence including at least 20 consecutive nucleotides having 100% sequence identity with at least 20 consecutive nucleotides of the nucleotide sequence of said nucleic acid of interest; and ii) an antisense nucleotide sequence including at least 20 consecutive nucleotides having 100% sequence identity with the complement of said at least 20 consecutive nucleotides of said sense nucleotide sequence; wherein the RNA is capable of forming an artificial hairpin RNA structure with a double stranded RNA stem by base-pairing between the regions with sense and antisense nucleotide sequence such that said at least 20 consecutive nucleotides of the sense sequence basepair with said at least 20 consecutive nucleotides of the antisense sequence, and wherein said DNA region comprises an intron; and c) a DNA region involved in transcription termination and polyadenylation.

33. A plant cell, comprising a nucleic acid of interest, which is normally capable of being phenotypically expressed, further comprising a chimeric DNA molecule comprising the following operably linked parts: a) a promoter, operative in said plant cell; b) a DNA region, which when transcribed, yields an RNA molecule with at least one RNA region with a nucleotide sequence comprising i) a sense nucleotide sequence including at least 20 consecutive nucleotides having 100% sequence identity with at least 20 consecutive nucleotides of the nucleotide sequence of the nucleic acid of interest; and ii) an antisense nucleotide sequence including at least 20 consecutive nucleotides having 100% sequence identity with the complement of said at least 20 consecutive nucleotides of said sense nucleotide sequence; wherein the RNA is capable of forming an artificial hairpin RNA structure with a double stranded RNA stem by base-pairing between the regions with sense and antisense nucleotide sequence, and wherein said DNA region comprises an intron; and c) a DNA region involved in transcription termination and polyadenylation.

34. A plant comprising the plant cell of claim 33.

35. A chimeric DNA comprising the following operably linked parts: a) a promoter, operative in a plant cell; b) a DNA region, which when transcribed, yields an RNA molecule comprising an RNA region capable of forming an artificial hairpin RNA structure comprising two annealing RNA sequences, wherein one of the annealing RNA sequences of the hairpin RNA structure comprises a sense sequence identical to at least 20 consecutive nucleotides of the nucleotide sequence of a nucleic acid of interest, and wherein the second of said annealing RNA sequences comprises an antisense sequence identical to at least 20 consecutive nucleotides of the complement of at least part of said nucleotide sequence of said nucleic acid of interest, and wherein said DNA region comprises an intron; and c) a DNA region involved in transcription termination and polyadenylation.

36. A chimeric DNA comprising the following operably linked parts: a) a promoter, operative in a plant cell; b) a DNA region, which when transcribed, yields an RNA molecule with a nucleotide sequence comprising i) a sense nucleotide sequence including at least 20 consecutive nucleotides having 100% sequence identity with at least 20 consecutive nucleotides of the nucleotide sequence of a nucleic acid of interest; and ii) an antisense nucleotide sequence including at least 20 consecutive nucleotides having 100% sequence identity with the complement of said at least 20 consecutive nucleotides of said sense nucleotide sequence; wherein the RNA is capable of forming an artificial hairpin RNA structure with a double stranded RNA stem by base-pairing between the regions with sense and antisense nucleotide sequence such that said at least 20 consecutive nucleotides of the sense sequence basepair with said at least 20 consecutive nucleotides of the antisense sequence, and wherein said DNA region comprises an intron; and c) a DNA region involved in transcription termination and polyadenylation.

37. The chimeric DNA of claim 25, wherein said RNA molecule further comprises a spacer nucleotide sequence located between said sense and said antisense nucleotide sequence.

38. The method of claim 32, wherein said RNA molecule further comprises a spacer nucleotide sequence located between said sense and said antisense nucleotide sequences.

39. The method of claim 32, wherein said intron is located between part of said DNA region which when transcribed yields said sense nucleotide sequence and part of said DNA region which when transcribed yields said antisense nucleotide sequence.

40. The method of claim 32, wherein said sense nucleotide sequence includes at least 50 consecutive nucleotides having 100% sequence identity with at least 50 consecutive nucleotides of the nucleotide sequence of said nucleic acid of interest, and said antisense nucleotide sequence includes at least 50 consecutive nucleotides having 100% sequence identity with the complement of said at least 50 consecutive nucleotides of said sense nucleotide sequence.

41. The method of claim 40, wherein said intron is located between part of said DNA region which when transcribed yields said sense nucleotide sequence and part of said DNA region which when transcribed yields said antisense nucleotide sequence.

42. The plant cell of claim 33, wherein said RNA molecule further comprises a spacer nucleotide sequence located between said sense and said antisense nucleotide sequences.

43. The plant cell of claim 33, wherein said intron is located between part of said DNA region which when transcribed yields said sense nucleotide sequence and part of said DNA region which when transcribed yields said antisense nucleotide sequence.

44. The plant cell of claim 33, wherein said sense nucleotide sequence includes at least 50 consecutive nucleotides having 100% sequence identity with at least 50 consecutive nucleotides of the nucleotide sequence of said nucleic acid of interest, and said antisense nucleotide sequence includes at least 50 consecutive nucleotides having 100% sequence identity with the complement of said at least 50 consecutive nucleotides of said sense nucleotide sequence.

45. The plant cell of claim 44, wherein said intron is located between part of said DNA region which when transcribed yields said sense nucleotide sequence and part of said DNA region which when transcribed yields said antisense nucleotide sequence.

46. The chimeric DNA of claim 36, wherein said RNA molecule further comprises a spacer nucleotide sequence located between said sense and said antisense nucleotide sequences.

47. The chimeric DNA of claim 36, wherein said intron is located between part of said DNA region which when transcribed yields said sense nucleotide sequence and part of said DNA region which when transcribed yields said antisense nucleotide sequence.

48. The chimeric DNA of claim 36, wherein said sense nucleotide sequence includes at least 50 consecutive nucleotides having 100% sequence identity with at least 50 consecutive nucleotides of the nucleotide sequence of said nucleic acid of interest, and said antisense nucleotide sequence includes at least 50 consecutive nucleotides having 100% sequence identity with the complement of said at least 50 consecutive nucleotides of said sense nucleotide sequence.

49. The chimeric DNA of claim 48, wherein said intron is located between part of said DNA region which when transcribed yields said sense nucleotide sequence and part of said DNA region which when transcribed yields said antisense nucleotide sequence.

Details for Patent 8,598,332

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 06/04/1986 ⤷  Try a Trial 2018-04-08
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b For Injection 103132 ⤷  Try a Trial 2018-04-08
Merck Sharp & Dohme Corp. INTRON A interferon alfa-2b Injection 103132 ⤷  Try a Trial 2018-04-08
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.